Bookmark
Forward
Explore Literature Results
Explore Clinical Trials Results
QuickView for CDK4 (gene)
Most Relevant Literature
- Diagnostic and management challenges for MDM2-, CDK4-negative fatty tumors of the retroperitoneum.
- CDK4/RB/E2Fs axis as potential therapeutic target of endometrial cancer.
- A refractory case of CDK4-amplified spinal astrocytoma achieving complete response upon treatment wi…
- Development of Selective Cyclin-Dependent Kinase 4 Inhibitors for Antineoplastic Therapies.
- The DNA deaminase APOBEC3B interacts with the cell-cycle protein CDK4 and disrupts CDK4-mediated nuc…
Most Relevant Clinical Trials
- To Identify Primary Resistance to CDK4/6 Inhibitors in Breast Cancer
- LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)
- A Trail of CDK4 / 6 Inhibitor and MEK Inhibitor in the Treatment of Metastatic Digestive System Tumo…
- Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Enc…
- Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced…
